The role of AQP4 in neuromyelitis optica: More answers, more questions

被引:27
|
作者
Yang, Xin [1 ,2 ]
Ransom, Bruce R. [3 ]
Ma, Jian-Fang [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200025, Peoples R China
[3] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98039 USA
关键词
Complement; Demyelination; Glutamate; Neuromyelitis optica; Potassium channel; Water channel protein aquaporin-4; MULTIPLE-SCLEROSIS; IN-VIVO; AQUAPORIN; 4; GLUTAMATE RECEPTORS; EXTRACELLULAR-SPACE; TRANSVERSE MYELITIS; GAP-JUNCTIONS; IGG BINDING; D-ASPARTATE; NMO-IGG;
D O I
10.1016/j.jneuroim.2016.06.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neuromyelitis optica (NMO) is a recurrent inflammatory disease that preferentially targets the optic nerves and spinal cord. The presence of antibodies to the water channel protein aquaporin-4 (AQP4), expressed almost exclusively in astrocytes in the central nervous system (CNS), is a reliable biomarker for NMO. These antibodies, NMO-IgG, may be responsible for the sequential cascade of immune events, including IgG/IgM deposition, infiltration of granulocytes and complement-mediated cytotoxicity (i.e. astrocyte loss) and demyelination. This review summarizes current thinking about the role of NMO-IgG in the pathogenesis of this condition. New insights were also generated along with important additional questions. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 50 条
  • [41] The use of AQP4-antibody testing in diagnosis Thai patients with neuromyelitis optica
    Siritho, Sasitorn
    Apiwattanakul, Metha
    Prayoonwiwat, Naraporn
    NEUROLOGY ASIA, 2014, 19 (04) : 375 - 385
  • [42] A Case of AQP4-IgG Neuromyelitis Optica Presenting with Orbital Inflammatory Syndrome
    Bailey, Lucy A.
    Riascos, Roy F.
    Adesina, Ore-Ofe O.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2025,
  • [43] Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis
    Hernandez, Zulma M.
    Cohen, Bruce A.
    Derwenskus, Joy
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2012, 1 (04) : 202 - 203
  • [44] The role of anti-aquaporin 4 antibody in the conversion of acute brainstem syndrome to neuromyelitis optica
    Cheng, Chen
    Jiang, Ying
    Lu, Xiaodong
    Gu, Fu
    Kang, Zhuang
    Dai, Yongqiang
    Lu, Zhengqi
    Hu, Xueqiang
    BMC NEUROLOGY, 2016, 16
  • [45] The role of AQP4 in the pathogenesis of depression, and possible related mechanisms
    Genel, Oktay
    Pariante, Carmine M.
    Borsini, Alessandra
    BRAIN BEHAVIOR AND IMMUNITY, 2021, 98 : 366 - 377
  • [46] Cognitive impairment in NMOSD-More questions than answers
    Czarnecka, Dominika
    Oset, Magdalena
    Karlinska, Iwona
    Stasiolek, Mariusz
    BRAIN AND BEHAVIOR, 2020, 10 (11):
  • [47] Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
    Palace, Jacqueline
    Lin, Dan-Yu
    Zeng, Donglin
    Majed, Masoud
    Elsone, Liene
    Hamid, Shand
    Messina, Silvia
    Misu, Tatsuro
    Sagen, Jessica
    Whittam, Daniel
    Takai, Yoshiki
    Leite, Maria Isabel
    Weinshenker, Brian
    Cabre, Philippe
    Jacob, Anu
    Nakashima, Ichiro
    Fujihara, Kazuo
    Pittock, Sean J.
    BRAIN, 2019, 142 : 1310 - 1323
  • [48] AQP4-IgG-positive neuromyelitis optica spectrum disorder with late onset in Mexico
    Delgado-Garcia, Guillermo
    Antonio-Luna, Emmanuel
    Lopez-Mena, Diego
    Rivas-Alonso, Veronica
    Flores-Rivera, Jose
    Corona-Vazquez, Teresa
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
  • [49] Does detection of anti-AQP4 antibodies trump clinical criteria for neuromyelitis optica?
    Weinshenker, Brian G.
    Carroll, William M.
    NEUROLOGY, 2011, 77 (09) : 812 - 813
  • [50] Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder
    Sun, Houliang
    Cui, Shilei
    Gao, Fei
    You, Qisheng
    Li, Yong
    Wang, Jiawei
    Zhang, Xiaojun
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 384 : 91 - 95